---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282688040.md"
description: "Eli Lilly will acquire biotech company CrossBridge Bio for up to $300 million in cash"
datetime: "2026-04-14T12:07:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282688040.md)
  - [en](https://longbridge.com/en/news/282688040.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282688040.md)
generator: "portal-rs"
---

# 

Eli Lilly will acquire biotech company CrossBridge Bio for up to $300 million in cash.

### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [MBIO.US](https://longbridge.com/en/quote/MBIO.US.md)
- [BBOT.US](https://longbridge.com/en/quote/BBOT.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [Benjamin Edwards Inc. Has $34.94 Million Stake in Eli Lilly and Company $LLY](https://longbridge.com/en/news/298002862.md)
- [Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.](https://longbridge.com/en/news/297565544.md)
- [Nxera Pharma to receive USD 8.6 million milestone payment from Centessa](https://longbridge.com/en/news/297870158.md)
- [Maloon Powers Pitre Higgins & Dennehy LLC Buys Shares of 908 Eli Lilly and Company $LLY](https://longbridge.com/en/news/298282618.md)
- [Eli Lilly's Taltz-Zepbound Combo Shows Encouraging Results At Week 52](https://longbridge.com/en/news/297510647.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**